• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板:仍然是止血障碍的一个治疗靶点。

Platelets: still a therapeutical target for haemostatic disorders.

作者信息

Geraldo Reinaldo Barros, Sathler Plínio Cunha, Lourenço André Luiz, Saito Max Seidy, Cabral Lucio M, Rampelotto Pabulo Henrique, Castro Helena Carla

机构信息

Programa de Pós-graduação em Ciências e Biotecnologia, Instituto de Biologia, Universidade Federal Fluminense (UFF), Niterói CEP 24210-130, RJ, Brazil.

Programa de Pós-graduação em Patologia, Departamento de Patologia, Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Niterói CEP 24030-215, RJ, Brazil.

出版信息

Int J Mol Sci. 2014 Oct 7;15(10):17901-19. doi: 10.3390/ijms151017901.

DOI:10.3390/ijms151017901
PMID:25295482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4227196/
Abstract

Platelets are cytoplasmatic fragments from bone marrow megakaryocytes present in blood. In this work, we review the basis of platelet mechanisms, their participation in syndromes and in arterial thrombosis, and their potential as a target for designing new antithrombotic agents. The option of new biotechnological sources is also explored.

摘要

血小板是血液中存在的骨髓巨核细胞的细胞质碎片。在这项工作中,我们综述了血小板机制的基础、它们在综合征和动脉血栓形成中的作用,以及它们作为设计新型抗血栓药物靶点的潜力。同时也探讨了新的生物技术来源的选择。

相似文献

1
Platelets: still a therapeutical target for haemostatic disorders.血小板:仍然是止血障碍的一个治疗靶点。
Int J Mol Sci. 2014 Oct 7;15(10):17901-19. doi: 10.3390/ijms151017901.
2
The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy.内皮衍生介质对双重抗血小板治疗疗效的重要性。
Expert Rev Hematol. 2016 Mar;9(3):223-5. doi: 10.1586/17474086.2016.1140035.
3
Platelet function and pharmacologic inhibition.血小板功能与药物抑制作用。
Vasc Endovascular Surg. 2006 Aug-Sep;40(4):261-7. doi: 10.1177/1538574406291794.
4
[Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].[阿司匹林抵抗:国际血栓与止血协会阿司匹林抵抗工作组立场文件]
Kardiologiia. 2005;45(7):75-6.
5
New thoughts on strategies for modulating platelet function through the inhibition of surface receptors.通过抑制表面受体调节血小板功能策略的新思考。
Haemostasis. 1996 Oct;26 Suppl 4:78-88. doi: 10.1159/000217288.
6
Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.δ-储存池缺乏症患者的ADP刺激血小板中胞质Ca2+增强增加——颗粒结合ADP与膜ADP受体之间相互作用的一个可能指标。
Thromb Haemost. 1997 Feb;77(2):376-82.
7
[Platelets and arterial thrombosis].[血小板与动脉血栓形成]
Bull Acad Natl Med. 2003;187(1):35-44; discussion 45-6.
8
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.动脉粥样硬化血栓形成疾病中血小板对阿司匹林和氯吡格雷的反应存在差异。
Circulation. 2007 Apr 24;115(16):2196-207. doi: 10.1161/CIRCULATIONAHA.106.675991.
9
Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.视网膜静脉阻塞中的血小板与脂蛋白(a):阿司匹林治疗的共同靶点
Thromb Haemost. 2007 Jun;97(6):1059-60.
10
Antiplatelet effect of aspirin in patients with coronary artery disease.阿司匹林对冠状动脉疾病患者的抗血小板作用。
Dan Med J. 2012 Sep;59(9):B4506.

引用本文的文献

1
Identification of molecular heterogeneity in telomere maintenance pathway of aplastic anemia.再生障碍性贫血端粒维持途径中分子异质性的鉴定。
Mol Biol Rep. 2025 Aug 23;52(1):843. doi: 10.1007/s11033-025-10942-0.
2
Unveiling the role of lipid metabolism in haemorrhagic disorders: genetic insights and therapeutic perspectives.揭示脂质代谢在出血性疾病中的作用:遗传学见解与治疗前景。
Thromb J. 2025 May 31;23(1):55. doi: 10.1186/s12959-025-00731-x.
3
Synthesis, Docking, and DFT Studies on Novel Schiff Base Sulfonamide Analogues as Selective COX-1 Inhibitors with Anti-Platelet Aggregation Activity.

本文引用的文献

1
Aspirin, Platelet P2Y12 Receptor Inhibitors, and Other Oral Antiplatelets: Comparative Pharmacology and Role in Elective PCI.阿司匹林、血小板P2Y12受体抑制剂及其他口服抗血小板药物:比较药理学及在择期经皮冠状动脉介入治疗中的作用
Interv Cardiol Clin. 2013 Oct;2(4):527-535. doi: 10.1016/j.iccl.2013.05.010. Epub 2013 Jul 10.
2
Apixaban for oral antithrombotic therapy: is a new era coming?阿哌沙班用于口服抗血栓治疗:新时代即将来临?
Mol Cell Ther. 2014 Feb 1;2:4. doi: 10.1186/2052-8426-2-4. eCollection 2014.
3
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.
新型席夫碱磺酰胺类似物作为具有抗血小板聚集活性的选择性COX-1抑制剂的合成、对接及密度泛函理论研究
Pharmaceuticals (Basel). 2024 May 30;17(6):710. doi: 10.3390/ph17060710.
4
PI3K Isoform Signalling in Platelets.血小板中的 PI3K 同工型信号转导
Curr Top Microbiol Immunol. 2022;436:255-285. doi: 10.1007/978-3-031-06566-8_11.
5
Platelet lysate for COVID-19 pneumonia-a newer adjunctive therapeutic avenue.用于新冠肺炎的血小板裂解物——一种新的辅助治疗途径。
Stem Cell Investig. 2021 Jun 8;8:11. doi: 10.21037/sci-2020-042. eCollection 2021.
6
ROS in Platelet Biology: Functional Aspects and Methodological Insights.ROS 在血小板生物学中的作用:功能方面和方法学见解。
Int J Mol Sci. 2020 Jul 9;21(14):4866. doi: 10.3390/ijms21144866.
7
Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.抗血小板治疗用于血管疾病并发症的二级预防。
Curr Atheroscler Rep. 2017 Nov 4;19(12):56. doi: 10.1007/s11883-017-0698-2.
8
Recent advancements in erythrocytes, platelets, and albumin as delivery systems.红细胞、血小板和白蛋白作为递送系统的最新进展。
Onco Targets Ther. 2016 May 17;9:2873-84. doi: 10.2147/OTT.S104691. eCollection 2016.
在阿司匹林抵抗而非阿司匹林敏感的受试者中,阿司匹林治疗后血小板糖蛋白IIIa的表达增加。
Br J Clin Pharmacol. 2014 Aug;78(2):320-8. doi: 10.1111/bcp.12335.
4
Transfusion efficacy of apheresis platelet concentrates irradiated at the day of transfusion is significantly superior compared to platelets irradiated in advance.与预先辐照的血小板相比,在输注当天辐照的机采血小板的输血效果显著更优。
Transfus Med Hemother. 2014 Jun;41(3):176-81. doi: 10.1159/000363484. Epub 2014 May 12.
5
Pharmacological regulation of platelet factors that influence tumor angiogenesis.影响肿瘤血管生成的血小板因子的药理学调节。
Semin Oncol. 2014 Jun;41(3):370-7. doi: 10.1053/j.seminoncol.2014.04.007. Epub 2014 Apr 24.
6
Platelet function tests: a review of progresses in clinical application.血小板功能检测:临床应用进展综述。
Biomed Res Int. 2014;2014:456569. doi: 10.1155/2014/456569. Epub 2014 May 8.
7
The functional role of platelets in the regulation of angiogenesis.血小板在血管生成调节中的功能作用。
Platelets. 2015;26(3):199-211. doi: 10.3109/09537104.2014.909022. Epub 2014 May 15.
8
The use of platelet function testing in PCI and CABG patients.经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)患者中血小板功能检测的应用。
Blood Rev. 2014 May;28(3):109-21. doi: 10.1016/j.blre.2014.03.004. Epub 2014 Apr 1.
9
Personalized platelet transfusions: one step closer to the clinic.个体化血小板输注:向临床又迈进了一步。
Cell Stem Cell. 2014 Apr 3;14(4):425-6. doi: 10.1016/j.stem.2014.03.012.
10
Platelets and cancer: a casual or causal relationship: revisited.血小板与癌症:偶然还是因果关系:再探讨
Cancer Metastasis Rev. 2014 Mar;33(1):231-69. doi: 10.1007/s10555-014-9498-0.